Effects of Chinese herb medicine Radix Scrophulariae on ventricular remodeling

Pharmazie

Volumn 65, Issue 10, 2010, Pages 770-775

  Gu, Wei Liang ^a   Chen, Chang Xun ^a   Wu, Qi ^a   Lü, Jian ^a   Liu, Ying ^a   Zhang, Shi Jie ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CAPTOPRIL; COLLAGEN; HYDROXYPROLINE; MESSENGER RNA; PICRIC ACID; PLANT EXTRACT; SCROPHULARIA NINGPOENSIS EXTRACT; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINESE HERB; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GENE EXPRESSION; HEART LEFT VENTRICLE; HEART MUSCLE; HEART VENTRICLE REMODELING; HEART WEIGHT; MALE; NONHUMAN; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCROPHULARIACEAE;

ANGIOTENSIN II; ANIMALS; COLLAGEN; CORONARY VESSELS; HYDROXYPROLINE; LIGATION; MALE; MYOCARDIAL INFARCTION; MYOCYTES, CARDIAC; ORGAN SIZE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ANGIOTENSIN, TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCROPHULARIA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VASOCONSTRICTOR AGENTS; VENTRICULAR REMODELING;

EID: 78349300545     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.0561     Document Type: Article

References (23)

1. Anversa P, Beghi C, Kikkawa Y, Olivetti G (1985) Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy. Am J Pathol 118: 484-492. (Pubitemid 15149815)
2. Brilla CG, Pick R, Tan LB, Janicki JS, Weber KT (1990) Remodeling of the rat right and left ventricles in experimental hypertension. Circ Res 67: 1355-1364.
3. Deblois D, Tea BS, Beaudry D, Hamet P (2005). Regulation of therapeutic apoptosis: a potential target in controlling hypertensive organ damage. Can J Physiol Pharmacol 83: 29-41. (Pubitemid 40754773)
4. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122:103-111. (Pubitemid 23188802)
5. Diniz GP, Carneiro-Ramos MS, Barreto-Chaves ML (2007) Angiotensin type 1 (AT1) and type 2 (AT2) receptors mediate the increase in TGF-beta1 in thyroid hormone-induced cardiac hypertrophy. Pflugers Arch 454: 75-81.
6. Frolkis I, Gurevitch J, Yuhas Y, Iaina A, Wollman Y, Chernichovski T, Paz Y, Matsa M, Pevni D, Kramer A, Shapira I, Mohr R (2001) Interaction between paracrine tumor necrosis factor-alpha and paracrine angiotensin II during myocardial ischemia. J Am Coll Cardiol 37: 316-322. (Pubitemid 32051756)
7. Gray MO, Long CS, Kalinyak JE, Li HT, Karliner JS (1998) Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. Cardiovasc Res 40: 352-363.
8. Gurlek A, Kilickap M, Dincer I, Dandachi R, Tutkak H, Oral D (2001) Effect of losartan on circulating TNFalpha levels and left ventricular systolic performance in patients with heart failure. J Cardiovasc Risk 8: 279-282. (Pubitemid 33010687)
9. Heeneman S, Cleutjens JP, Faber BC, Creemers EE, van Suylen RJ, Lutgens E, Cleutjens KB, Daemen MJ (2003) The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J Pathol 200: 516-525. (Pubitemid 36818252)
10. Irwin MW, Mak S, Mann DL, Qu R, Penninger JM, Yan A, Dawood F, Wen WH, Shou Z, Liu P (1999) Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium. Circulation 99: 1492-1498. (Pubitemid 29140917)
11. Jialin Teng, Xingguang Li, Yimin Le (2007) Chinese Materia Medica 9: 344.
12. Jugdutt BI, Amy RW (1986) Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography. J Am Coll Cardiol 7: 91-102. (Pubitemid 16132461)
13. Jugdutt BI, Joljart MJ, Khan MI (1996) Rate of collagen deposition during healing and ventricular remodeling after myocardial infarction in rat and dog models. Circulation 94: 94-101.
14. Paul S (1995) The pathophysiologic process of ventricular remodeling: from infarct to failure. Crit Care Nurs Q 18: 7-21.
15. Sadoshima J, Izumo S (1993) Molecular characterization of angiotensin II -induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 73: 413-423.
16. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H (1994) Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 89: 2273-2282. (Pubitemid 24142808)
17. Schunkert H, Dzau VJ, Tahn SS, Hirsch AT, Apstein CS, Lorell BH (1990) Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J Clin Invest 86: 1913-1920.
18. Shinzato T, Ohya Y, Nakamoto M, Ishida A, Takishita S (2007) Beneficial effects of pioglitazone on left ventricular hypertrophy in genetically hypertensive rats. Hypertens Res 30: 863-873. (Pubitemid 47578249)
19. Tenhumen O, Rysa J, Ilves M, Soini Y, Rushkoaho H, Leskinen H (2006) Identification of cell cycle regulatory andinflammatory genes as predominant targets of p38 mitogenactivated protein kinase in the heart. Circ Res 99: 485-493. (Pubitemid 44337820)
20. Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, LeJemtel TH (1996) Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 28: 964-971. (Pubitemid 26348163)
21. Tsutamoto T, Wada A, Maeda K, Mabuchi N, Hayashi M, Tsutsui T, Ohnishi M, Sawaki M, Fujii M, Matsumoto T, Kinoshita M (2000) Angiotensin II type 1 receptor antagonist decreases plasma levels of tumor necrosis factor alpha, interleukin-6 and soluble adhesion molecules in patients with chronic heart failure. J Am Coll Cardiol 35: 714-721. (Pubitemid 30167029)
22. van Krimpen C, Schoemaker RG, Cleutjens JP, Smits JF, Struyker-Boudier HA, Bosman FT, Daemen MJ (1991) Angiotensin I converting enzyme inhibitors and cardiac remodeling. Basic Res Cardiol 86: 149-155.
23. Weber KT (1989) Cardiac interstitium in health and disease: the fibrillar collagen network. J Am Coll Cardiol 13: 1637-1652.